Evaluating Attitudes Toward HPV Vaccinations in Pharmacies

Immunogenicity of HPV Vaccine in Transplant Recipients.

Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV

Effectiveness of the Q-HPV Vaccine 9-years Post Vaccination Among HIV Positive Adolescents

Long Term Immune Memory Responses to HPV Vaccination Following 2 vs 3 Doses of Quad-HPV Vaccine

Does the HPV Vaccine Cause the Same Response in Adolescent Kidney and Liver Transplant Patients as in Healthy Controls?

V503 in Chinese Girls 9-14 Years Old Versus Chinese Women 20-26 Years Old (V503-071)

Immunogenicity and Safety of V503 in Chinese Males 9 Through 19 Years Old (V503-053)

Safety and Immunogenicity of 9-valent Human Papillomavirus (9vHPV) Vaccine Coadministered With Messenger Ribonucleic Acid (mRNA)-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) (COVID-19) Vaccine (V503-076)

Immunogenicity and Safety of the 9-valent Human Papillomavirus (9vHPV) Vaccine in Japanese Boys and Girls (V503-066)

Safety and Immunogenicity of Extended 2-dose Regimens of 9-valent Human Papillomavirus (9vHPV) Vaccine (V503-069)

Nonavalent Prophylactic HPV Vaccine (GARDASIL9) After Local Conservative The NOVEL Trial

HPV Vaccination in Africa- New Delivery Schedules Alias The HANDS HPV Vaccine Trial

HPV Vaccine Therapy in Reducing High-Grade Cervical Lesions in Patients With HIV and HPV

Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)

4-valent HPV Vaccine to Treat Recurrent Respiratory Papillomatosis in Children

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Broad Spectrum HPV Vaccine Tolerability, Immunogenicity, and Efficacy Study (V502-003)

Broad Spectrum HPV Vaccine Dose Ranging Study (V502-001)

Use of a Patient Education/Messaging Platform to Increase Uptake and Series Completion of the HPV Vaccine

An Open-Label, Single Dose Safety Study of Quadrivalent HPV Vaccine in Chinese Female Subjects (V501-035)

Broad Spectrum HPV Vaccine Dose Escalation Study (V502-002)

"Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake

Evaluation of a Vaccine Chatbot on HPV Vaccine Confidence and Hesitancy

County Level Correlates of HPV Vaccine Series Completion Among Children Ages 11-14 Years in Indiana

Retrospective Cohort Study of the Effectiveness of the Prophylactic Vaccine Against the Human Papilloma Virus in the Prevention of Recurrence in Women Who Have Received an Excisional Therapy by HSIL / CIN.

The Prospective Cohort Study to Evaluate the Preventive Efficacy of HPV Vaccine in Japanese Women Aged 27-45 Years

In the Era of the HPV Vaccine, What Are The Current HPV Subtypes Contributing to High Grade Cervical Dysplasia, Adenocarcinoma in Situ, and Early Cervical Cancer?

Antibody Response to Prophylactic QHPV Vaccine at 48 Months Among HIV-infected Girls and Boys

Adolescent Vaccination in Pharmacies

Long Term Follow-up of HPV Vaccine in HIV (CTN 236)

A Cohort Study to Assess Sustained Immunogenicity to qHPV Vaccine Among HIV-infected Girls and Boys Age 9-14 Years

A Study to Compare the Impact of a School Based HPV Program on Vaccination Uptake and Completion Rates

HPV Vaccine Acceptability Among Young Men Who Have Sex With Men

Mother - Daughter Initiative (MDI) in Cervical Cancer Prevention

Brief Interventions to Increase HPV Vaccine Acceptance in School-based Health Centers

Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women